183 related articles for article (PubMed ID: 38602492)
1. Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced Bioactivity.
Machushynets NV; Al Ayed K; Terlouw BR; Du C; Buijs NP; Willemse J; Elsayed SS; Schill J; Trebosc V; Pieren M; Alexander FM; Cochrane SA; Liles MR; Medema MH; Martin NI; van Wezel GP
ACS Chem Biol; 2024 May; 19(5):1106-1115. PubMed ID: 38602492
[TBL] [Abstract][Full Text] [Related]
2. Key residues in octyl-tridecaptin A1 analogues linked to stable secondary structures in the membrane.
Cochrane SA; Findlay B; Vederas JC; Ratemi ES
Chembiochem; 2014 Jun; 15(9):1295-9. PubMed ID: 24816483
[TBL] [Abstract][Full Text] [Related]
3. Biochemical, structural, and genetic characterization of tridecaptin A₁, an antagonist of Campylobacter jejuni.
Lohans CT; van Belkum MJ; Cochrane SA; Huang Z; Sit CS; McMullen LM; Vederas JC
Chembiochem; 2014 Jan; 15(2):243-9. PubMed ID: 24382692
[TBL] [Abstract][Full Text] [Related]
4. A novel family of non-secreted tridecaptin lipopeptide produced by Paenibacillus elgii.
da Costa RA; Andrade IEPC; Pinto OHB; de Souza BBP; Fulgêncio DLA; Mendonça ML; Kurokawa AS; Ortega DB; Carvalho LS; Krüger RH; Ramada MHS; Barreto CC
Amino Acids; 2022 Nov; 54(11):1477-1489. PubMed ID: 35864259
[TBL] [Abstract][Full Text] [Related]
5. Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant
Jangra M; Kaur M; Tambat R; Rana R; Maurya SK; Khatri N; Ghafur A; Nandanwar H
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936101
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II.
Cochrane SA; Findlay B; Bakhtiary A; Acedo JZ; Rodriguez-Lopez EM; Mercier P; Vederas JC
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11561-11566. PubMed ID: 27688760
[TBL] [Abstract][Full Text] [Related]
7. Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampin against Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa.
Domalaon R; Sanchak Y; Koskei LC; Lyu Y; Zhanel GG; Arthur G; Schweizer F
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437631
[TBL] [Abstract][Full Text] [Related]
8. Purification and biological activity of natural variants synthesized by tridecaptin M gene cluster and in vitro drug-kinetics of this antibiotic class.
Jangra M; Kaur M; Podia M; Tambat R; Singh V; Chandal N; Mahey N; Maurya N; Nandanwar H
Sci Rep; 2019 Dec; 9(1):18870. PubMed ID: 31827113
[TBL] [Abstract][Full Text] [Related]
9. Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A
Ballantine RD; Li YX; Qian PY; Cochrane SA
Chem Commun (Camb); 2018 Sep; 54(75):10634-10637. PubMed ID: 30179243
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship studies of N-terminal analogues of the antimicrobial peptide tridecaptin A(1).
Cochrane SA; Lohans CT; Brandelli JR; Mulvey G; Armstrong GD; Vederas JC
J Med Chem; 2014 Feb; 57(3):1127-31. PubMed ID: 24479847
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Paenibacillaceae Family Gram-Negative-Active Cationic Lipopeptide Antibiotics Using Evolution-Guided Chemical Synthesis.
Wang Z; Koirala B; Hernandez Y; Brady SF
Org Lett; 2022 Jul; 24(27):4943-4948. PubMed ID: 35776528
[TBL] [Abstract][Full Text] [Related]
12. Isolation and partial characterization of cyclic lipopeptide antibiotics produced by Paenibacillus ehimensis B7.
Huang Z; Hu Y; Shou L; Song M
BMC Microbiol; 2013 Apr; 13():87. PubMed ID: 23594351
[TBL] [Abstract][Full Text] [Related]
13. Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position.
Jensen SK; Thomsen TT; Oddo A; Franzyk H; Løbner-Olesen A; Hansen PR
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823798
[TBL] [Abstract][Full Text] [Related]
14. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
[TBL] [Abstract][Full Text] [Related]
15. Glycosylated Lipopeptides-Synthesis and Evaluation of Antimicrobial Activity and Cytotoxicity.
Sikora K; Bauer M; Bartoszewska S; Neubauer D; Kamysz W
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671557
[TBL] [Abstract][Full Text] [Related]
16. A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.
Liu Y; Ding S; Dietrich R; Märtlbauer E; Zhu K
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1486-1490. PubMed ID: 28106348
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities.
Bionda N; Fleeman RM; de la Fuente-Núñez C; Rodriguez MC; Reffuveille F; Shaw LN; Pastar I; Davis SC; Hancock REW; Cudic P
Eur J Med Chem; 2016 Jan; 108():354-363. PubMed ID: 26703794
[TBL] [Abstract][Full Text] [Related]
18. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
[TBL] [Abstract][Full Text] [Related]
19. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria.
Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K
J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891
[TBL] [Abstract][Full Text] [Related]
20. Initial efforts toward the optimization of arylomycins for antibiotic activity.
Roberts TC; Schallenberger MA; Liu J; Smith PA; Romesberg FE
J Med Chem; 2011 Jul; 54(14):4954-63. PubMed ID: 21630667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
